<DOC>
	<DOCNO>NCT02583022</DOCNO>
	<brief_summary>The study Phase II , single center , randomize , open-label , placebo-controlled study male female subject , age â‰¥ 20 year mild moderate atopic dermatitis . All subject receive BID topical application PAC-14028 cream vehicle Elidel cream 4 week .</brief_summary>
	<brief_title>A Study Evaluate Safety Efficacy PAC-14028 Cream Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Pimecrolimus</mesh_term>
	<criteria>Male female patient age 20 65 year old Patients atopic dermatitis , diagnose accord Hanifin Rajka diagnostic criterion SCORAD ( SCORing Atopic Dermatitis ) Score le 40 Patients present symptom systemic infection screen Patients treated oral steroid , oral antibiotic , systemic phototherapy , immunosuppressant within last 1 month prior investigational product administration Patients treat topical steroid antibiotic within last 2 week prior investigational product administration Pregnant woman breastfeed woman Women childbearing potential woman plan pregnancy study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>